Trial of Carvedilol in Alzheimer's Disease

PHASE4CompletedINTERVENTIONAL
Enrollment

29

Participants

Timeline

Start Date

June 30, 2011

Primary Completion Date

December 31, 2016

Study Completion Date

January 31, 2017

Conditions
Alzheimer's Disease
Interventions
DRUG

Carvedilol

target dose of 25 mg daily which is half the maximum dose used in clinical practice

DRUG

Placebo

a pill that will look like the active drug but will not contain any carvedilol

Trial Locations (1)

21224

Johns Hopkins School of Medicine Bayview Campus, Baltimore

All Listed Sponsors
collaborator

Icahn School of Medicine at Mount Sinai

OTHER

lead

Johns Hopkins University

OTHER

NCT01354444 - Trial of Carvedilol in Alzheimer's Disease | Biotech Hunter | Biotech Hunter